| Teva Pharma AG - Trisenox 10 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 65178 | | 01 | | Trisenox 10 mg/10 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01XX27 | | Arsenic Trioxide | | 10.12.2014 | | |
|
| Composition |
| arsenii trioxidum 10 mg, natrii hydroxidum, natrii hydroxidi solutio 1 mol/L, acidum hydrochloridum, aqua ad iniectabilia q.s. ad solutionem pro 10 ml corresp. natrium 6.9 mg. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | Active Agent | Dose |
|---|
| Arsenii Trioxidum | 10mg / 10ml |
| | | | Inactive agents | Dose |
|---|
| Acidum Hydrochloridum | | | Mol/l | | | Natrii Hydroxidi Solutio | 1 | | Sodium Hydroxide | |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
